Draegerwerk Delivers Solid Business Performance in Q1 2024

• Drägerwerk AG & Co. KGaA reported solid business performance in Q1 2024 with order intake slightly above the high prior-year level.
• Net sales and earnings were below the strong prior-year quarter due to base effects, with net sales falling by 2.6 percent to around EUR 735.8 million.
• Earnings before interest and taxes (EBIT) amounted to EUR 15.1 million, with an EBIT margin of 2.0 percent.
• In the safety division, order intake rose by 6.1 percent to EUR 357.2 million, driven by occupational health and safety equipment, respiratory and personal protection products, and alcohol and drug testing devices.
• In the medical division, order intake decreased by 1.9 percent to EUR 453.7 million, due to the lack of a renewed wave of demand for ventilators in China.
• Drägerwerk confirmed its annual forecast, anticipating net sales growth of 1.0 to 5.0 percent and an EBIT margin of 2.5 to 5.5 percent.

The price of Draegerwerk at the time of the news was 50,33EUR and was up +0,05 % compared with the previous day.
20 minutes after the article was published, the price was 50,38EUR this corresponds to a plus of +0,10 % since publication.
At this time, the index SDAX was at 14.207,92PKT (-0,34 %).

Draegerwerk

+0,50 %

+2,66 %

-0,59 %

+9,85 %

0,00 %

-35,14 %

-5,10 %

-39,77 %

+1.218,28 %

ISIN:DE0005550636WKN:555063

• Intraday
• 5 Tage
• 1 Monat
• 3M
• 1 Jahr
• 3J
• 5J
• 10J
• Max